Contrary to increasing the life span of DCs, the same groups also reported that acute or brief exposure to rapamycin in DCs also makes them potent activators of antigen specific CD8+ T cells, thus enhancing control of B16 melanoma as vaccination in mice [63]. The gene discussed is CD8A; the disease is melanoma.